Sign in
4

Changes in Ownership

Teladoc Health, Inc. Filed Acc 0001415889-23-004107

SVP - CORPORATE DEVELOPMENT sold 1,801 shares at $25.36 ($45,677)

  • SVP - CORPORATE DEVELOPMENT acquired 11,608 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Turitz Andrew · SVP - CORPORATE DEVELOPMENT

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-01 Exercise or conversion : show line 1 in the form +5,389 20,183 D
2023-03-02 Sale : show line 2 in the form −1,801 $25.36 $45,677 18,382 D
2023-03-02 Exercise or conversion : show line 3 in the form +1,205 19,587 D
2023-03-02 Exercise or conversion : show line 4 in the form +2,048 21,635 D
2023-03-02 Exercise or conversion : show line 5 in the form +515 22,150 D
2023-03-02 Exercise or conversion : show line 6 in the form +1,147 23,297 D
2023-03-02 Exercise or conversion : show line 7 in the form +867 24,164 D
2023-03-02 Exercise or conversion : show line 8 in the form +437 24,601 D
Open-market sales · 1,801 sh · avg $25.36 · $45,677

Table II: Derivative

8 lines
Date Transaction Shares Owned after D/I
2023-03-01 Exercise or conversion : show line 9 in the form Restricted Stock Units −5,389 10,781 D
2023-03-02 Exercise or conversion : show line 10 in the form Restricted Stock Units −1,205 0 D
2023-03-02 Exercise or conversion : show line 11 in the form Performance Stock Units −2,048 0 D
2023-03-02 Exercise or conversion : show line 12 in the form Performance Stock Units −515 0 D
2023-03-02 Exercise or conversion : show line 13 in the form Restricted Stock Units −1,147 1,148 D
2023-03-02 Exercise or conversion : show line 14 in the form Performance Stock Units −867 867 D
2023-03-02 Grant or award : show line 15 in the form Performance Stock Units +874 874 D
2023-03-02 Exercise or conversion : show line 16 in the form Performance Stock Units −437 437 D
Loading xslF345X03/form4-03032023_090316.xml…